Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (171-180 of 272) with videos related to

Pageof 28
Sort By:
Preventive Medicine|May 6, 2019
Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the NetherlandsNicole J Polman, Yanne de Haan, Nienke J Veldhuijzen, et al.
Journal of Clinical Pathology|October 7, 2010
p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesionsMaaike G Dijkstra, Daniëlle A M Heideman, Sabine C de Roy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2015
Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in KenyaHugo De Vuyst, Silvia Franceschi, Martyn Plummer, et al.
International Journal of Cancer|November 1, 2008
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderChris J L M Meijer, Johannes Berkhof, Philip E Castle, et al.
British Journal of Cancer|September 3, 2010
Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening testD C Rijkaart, V M H Coupe, F J van Kemenade, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technologyD T Geraets, D A M Heideman, M N C de Koning, et al.
Journal of Clinical Medicine|June 10, 2020
Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility StudyJamie J Beagan, Nina R Sluiter, Sander Bach, et al.
BMJ (Clinical Research Ed.)|March 13, 2010
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort studyMurat Gök, Daniëlle A M Heideman, Folkert J van Kemenade, et al.
Journal of Clinical Microbiology|May 4, 2012
High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytologyD C Rijkaart, D A M Heideman, V M H Coupe, et al.
International Journal of Cancer|June 8, 2019
Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV statusTharcisse Mpunga, Marie Chantal Umulisa, Vanessa Tenet, et al.
Pageof 28

Showing results (171-180 of 272) with videos related to

Sort By:
Pageof 28
Preventive Medicine|May 6, 2019
Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the NetherlandsNicole J Polman, Yanne de Haan, Nienke J Veldhuijzen, et al.
Journal of Clinical Pathology|October 7, 2010
p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesionsMaaike G Dijkstra, Daniëlle A M Heideman, Sabine C de Roy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2015
Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in KenyaHugo De Vuyst, Silvia Franceschi, Martyn Plummer, et al.
International Journal of Cancer|November 1, 2008
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderChris J L M Meijer, Johannes Berkhof, Philip E Castle, et al.
British Journal of Cancer|September 3, 2010
Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening testD C Rijkaart, V M H Coupe, F J van Kemenade, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technologyD T Geraets, D A M Heideman, M N C de Koning, et al.
Journal of Clinical Medicine|June 10, 2020
Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility StudyJamie J Beagan, Nina R Sluiter, Sander Bach, et al.
BMJ (Clinical Research Ed.)|March 13, 2010
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort studyMurat Gök, Daniëlle A M Heideman, Folkert J van Kemenade, et al.
Journal of Clinical Microbiology|May 4, 2012
High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytologyD C Rijkaart, D A M Heideman, V M H Coupe, et al.
International Journal of Cancer|June 8, 2019
Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV statusTharcisse Mpunga, Marie Chantal Umulisa, Vanessa Tenet, et al.
Pageof 28